ARTICLE | Clinical News
Soolantra ivermectin 1% regulatory update
January 19, 2015 8:00 AM UTC
FDA approved an NDA for once-daily Soolantra ivermectin 1% cream from Galderma to treat inflammatory lesions of rosacea. Ivermectin is a semi-synthetic macrocyclic lactone derivative. ...